Viewing Study NCT01681095

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:17 PM
Ignite Modification Date: 2026-01-25 @ 6:19 AM
Study NCT ID: NCT01681095
Status: COMPLETED
Last Update Posted: 2019-08-06
First Post: 2012-08-10
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Custodiol-HTK (Histidine-tryptophan-ketoglutarate) Solution as a Cardioplegic Agent
Sponsor: Marc Sakwa, MD
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Coronary Artery Disease View
None Myocardial Ischemia View
None Coronary Disease View
None Heart Diseases View
None Valvular Heart Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Physiological Effects of Drugs View
None Cardiovascular Agents View
None Therapeutic Uses View
None Pharmacologic Actions View
None Mannitol View
None Cardiac Surgery View
None Cardioplegic Solutions View
None HTK solution View
None Myocardial protection View
None Coronary Artery Disease View
None Myocardial Ischemia View
None Coronary Disease View
None Heart Diseases View